Company intelligence / Profile preview

Arboris

Savannah, Georgia, United States

Ownership: Private
Development stage: Other

Overview

Arboris is the world’s largest producer of phytosterols, with a 99% pure mixture of non-GMO, renewably sourced plant sterols. Its products are used in heart-healthy functional foods for cholesterol reduction and as starting materials for various steroidal active pharmaceutical ingredients. Its sterols are approved for food and pharma use in the US, EU, and Canada.

Therapeutic areas: EndocrinologyCardiovascular
Modalities: Small moleculeBiologic
Industry: Chemicals & Materials

Partnerships

None disclosed; strong customer alliances in food and pharmaceutical sectors

Beyond the preview

Go deeper on Arboris.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arboris.

Explore the full profile